The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hi CB
It's not our job to spot the errors in these RNSs. They need to take their work a bit more seriously. If they did, these errors wouldn't continually happen but I get the impression that they just don't care.
I am seriously considering selling my Cyan holding and investing some of it in MINI instead. I have been investing modest amounts with Mr Williams for a few months. Eventually, the fund could be holding 14% of Cyan's shares. Somehow or other, GW seems to have outmanoeuvred the BoD.
GL
ITT
Two years ago, Hardman were saying:-
"The analysis produces an implied fair enterprise value of £87.9m and an implied fair equity value of £89.6m (equating to £0.41 per share). These valuation outcomes are materially higher than the current enterprise value of £24.5m and market capitalisation of £26.2m."
After the BoD have 'given' a huge chunk of the company away, this now translates to a fair equity (pie in the sky) value of 27p per share instead of 41p (a 34% decrease).
Great work.
Unfortunately, Cyan isn't a business that's attempting to make a profit - it's an ego trip for one guy, which is why the UK taxpayer shouldn't be propping it up with R&D tax credits & EIS relief for wealthy individuals who, by the way, shouldn't be receiving State Benefits. Talk about undeserving scroungers.
Apart from tenbagging, I wish that I'd never stumbled across this crock of proverbial.
Good luck with getting your monthly reports.
Hi jakeandelwood
My advice (for what it's worth) to JC & Co is to button it for a while. There's nothing that they can say that will impact positively on the SP - until they release a substantial Genus order (joke).
Cheers
ITT
here we go. are you ready?
"congratulations to creo medical for achieving a record growth rate of 9,260% between 2019 and 2021."
dig a tiny bit deeper and you find that their revenue grew from £13k in 2019 to £227k in 2021.
this is all part of the box ticking required to ensure that they don't **** up cyan's eis qualification, being probably the oldest 'start-up' to ever receive eis support.
Hi jakeandelwood
I'll have you know that the 50 fastest-growing businesses in each region have been identified through robust research conducted by the Ideas Forums team, led by Professor Dylan Jones-Evans, the creator of the Wales Fast Growth 50 and a leading entrepreneurship academic, who loves a good knees up.
Apparently, it's an initiative that has been running in Wales for 25 years.
www.fastgrowth50.com/midseast2023/
I'm going to have a look for last year's Welsh winner - results later.
Effing hopeless.
ITT
Even if the BoD are not directly responsible for the dramatic decline in the SP, they haven't been shy in coming forward and taking full advantage of its weakness, after doing nothing whatsoever in their power to support it.
I wonder at what price the next coordinated selling by our major shareholders has been agreed at? It will become apparent in due course.
They were in such a rush to get the share options RNS out on Friday, I'm sure that there's yet another typo.
Heather's don't total 682,642, they total the same as JC's (i.e. 1,548,949).
Let's have another RNS on Monday to tidy this up, please.
There's plenty more dilution to come on top of this latest 20% of the company @ 12p.
Not even their paid brokers can predict when the company will have any cash. They're saying that there'll be a £1m cash shortfall as at 31/03/25, and that's after turning over £30M+ in that year.
One way or another, these sellers must know that they're not going be caught with their pants down. Enough said.
I look forward to the day (if it ever arrives) that Cyan proves that it does in fact have a proper business and is not a 'sucker stock', as categorised by www.stockopedia.com.
www.stockopedia.com/share-prices/cyanconnode-holdings-LON:CYAN/
Perhaps 2024/2025 will be the year.